Quantcast
Home > Quotes > HTGM

HTG Molecular Diagnostics, Inc. Common Stock (HTGM) Quote & Summary Data

HTGM 
$2.53
*  
0.03
1.17%
Get HTGM Alerts
*Delayed - data as of Mar. 20, 2019  -  Find a broker to begin trading HTGM now
Exchange:NASDAQ
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
6
Today's High / Low
$ 2.62 / $ 2.47
Share Volume
154,065
50 Day Avg. Daily Volume
370,399
Previous Close
$ 2.56
52 Week High / Low
$ 5.83 / $ 2.03
Market Cap
72,373,210
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.27

Intraday Chart

Shares Traded

Share Volume:
154,065
50 Day Avg. Daily Volume:
370,399

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.60

Trading Range

The current last sale of $2.53 is 24.63% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.62 $ 5.83
 Low: $ 2.47 $ 2.03

Company Description (as filed with the SEC)

We are a commercial stage life sciences company focused on advancing the promise of precision medicine. Our product and service solutions are based on our proprietary next generation digital HTG EdgeSeq technology that enables the detection and measurement of biomarkers using a small amount of biological sample, in liquid or solid forms. Our menu of HTG EdgeSeq assays are automated on our HTG EdgeSeq platform, which applies genetic sequencing tools that generate expression data in a timely manner utilizing a simplified workflow for customers. We seek to leverage key business drivers in molecular profiling for biomarker analysis and diagnostics, including the acceleration of precision medicine, the migration of molecular testing to NGS-based applications, the movement to smaller and less invasive biopsies, the need for greater diagnostic sensitivity, the need to conform to challenging healthcare economics and the need for automation and an easily deployable workflow.  ... More ...  



Risk Grade

Where does HTGM fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.57
Open Date:
Mar. 20, 2019
Close Price:
$ 2.53
Close Date:
Mar. 20, 2019


Consensus Recommendation

Analyst Info